about
Epidemiologic evidence for multiple sclerosis as an infectionAnalysis of MHC class II DP, DQ and DR alleles in Crohn's diseaseCrystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic proteinProteomic analysis of multiple sclerosis cerebrospinal fluidQuantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.The mystery of the origin of multiple sclerosisOccurrence of multiple sclerosis in the north and south of New ZealandSib risk and the dizygotic twin concordance rate for multiple sclerosis.Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseasesNovel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.B cells in multiple sclerosis.Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models.Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic proteinIdentification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones.Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseasesIdentification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanismsPreferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.Asymptotic properties of affected-sib-pair linkage analysis.Assessing the role of HLA-linked and unlinked determinants of disease.The search for virus in multiple sclerosis brain.Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.Multiple sclerosis: nature or nurture?Chlamydia: a role for multiple sclerosis or more confusion?Histocompatibility determinants in childhood postinfectious encephalomyelitis.Viruses and multiple sclerosis
P2860
Q24615844-D8F19FD7-821D-431E-912C-1FC3232B21FAQ24670577-059C86E9-9271-4AA6-A50D-2FE54B69BAB9Q27765717-4A5E172F-B5DB-4BD2-9421-B8ADB664B653Q28269026-9E8CC757-1E31-496E-BD6B-D665B50E3087Q33481896-B6DC7440-8327-4585-B3CF-1CD0859EAC74Q33621902-50E46107-285C-4BFA-B91B-DDC40A3103FFQ33627181-EB6F499A-352A-4A05-8D4B-187E1587F45CQ33685436-84B10F72-A406-4754-91BF-4B46887557A6Q33819182-6D142234-1519-486C-B6E3-E41CEA752060Q34556850-33D5FE3F-7A8B-46D6-9A49-3DC04A619185Q34577259-E0513BA3-22B6-458B-A767-6F169BA93661Q34792611-20FA2DB1-5DFD-4347-9A69-A8451383DE07Q35650942-DD681564-6CF1-4C25-9BEC-4E0D9505C9AEQ36255695-A70D1AD6-EB6B-45AA-9EA4-724BA995F2F5Q36288434-E311F0BF-FE2C-465F-9116-65E801F2B222Q36322630-E6D9E9A0-610C-488C-A979-47B0EEABFD67Q36349763-CB321251-5250-4F05-A75A-656BD214FF96Q36364807-4197A6D9-7484-4111-BA74-E33C9E82A4AEQ36800803-407D8362-7A27-4090-9A71-2643064AB8D8Q37415917-FA2B372A-3DF7-4EB8-B114-6772321B8158Q37607593-5570E5B8-6759-4C63-B4A6-AD1BD0B978C1Q40535037-53D4371B-9F6C-4752-99BD-A33CA64A7AA3Q40593830-13B22841-551F-487C-A7AA-32C11FF308AEQ41622000-CB2E71EC-FA2D-4BCE-A53D-D278813DCCF0Q42011739-325BE289-94A0-4B70-9C45-B1EF2165F376Q43166016-CE6DA07C-65F9-4467-9909-8DC47EAE5F54Q43428225-9538F657-89AD-46A6-9615-1F39FA6FEA49Q43879027-F9F27AA1-24D4-4FD2-958B-297BBC6C5EE7Q57001708-028641CC-2D6F-4D95-B335-C5D85E6A0D66
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
The genetics of susceptibility to multiple sclerosis.
@en
type
label
The genetics of susceptibility to multiple sclerosis.
@en
prefLabel
The genetics of susceptibility to multiple sclerosis.
@en
P1476
The genetics of susceptibility to multiple sclerosis.
@en
P2093
Nathanson N
Spielman RS
P356
10.1093/OXFORDJOURNALS.EPIREV.A036251
P577
1982-01-01T00:00:00Z